Three-question Skindex-Mini measures quality of life in children with atopic dermatitis.

To the Editor: Skin disorders are often highly visible, pruritic, and painful, leading to considerable burden. Patient-reported symptoms and impacts of skin disease are important in determining well-being but are often missed in physician assessments and do not correlate well with visible signs of disease.1 The Skindex-29, Skindex-16, and Skindex-Teen are validated instruments that measure patients’ perceptions of the impact of skin disease on quality of life.1 The Skindex-Mini, a 3-item questionnaire assessing 3 domains (symptoms, emotions, and function), was created to retain the validity and reliability of its Skindex predecessors while prioritizing ease of use at in-office visits.